DYN - Dyne Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DYN is currently covered by 10 analysts with an average price target of $32.4. This is a potential upside of $22.15 (216.1%) from yesterday's end of day stock price of $10.25.

Dyne Therapeutics 's activity chart (see below) currently has 26 price targets and 69 ratings on display. The stock rating distribution of DYN is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.45% with an average time for these price targets to be met of 237.2 days.

Highest price target for DYN is $52, Lowest price target is $9, average price target is $36.5.

Most recent stock forecast was given by PAUL MATTEIS from STIFEL on 31-Jul-2025. First documented stock forecast 12-Oct-2020.

Split History since 2000:

5/25/10 1 for 5

8/22/00 2 for 1

2/1/00 69 for 100

Currently out of the existing stock ratings of DYN, 48 are a BUY (94.12%), 3 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$36

$26.15 (265.48%)

$66

5 days ago
(31-Jul-2025)

4/6 (66.67%)

$26.15 (265.48%)

509

Buy

$38

$28.15 (285.79%)

$50

7 days ago
(29-Jul-2025)

6/12 (50%)

$28.8 (313.04%)

197

Buy

$23

$13.15 (133.50%)

$45

7 days ago
(29-Jul-2025)

0/3 (0%)

$13.8 (150.00%)

Hold

$9

$-0.85 (-8.63%)

$17

21 days ago
(15-Jul-2025)

5/7 (71.43%)

$0.72 (8.70%)

129

Buy

$50

$40.15 (407.61%)

1 months 18 days ago
(18-Jun-2025)

2/4 (50%)

$39.22 (363.82%)

302

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DYN (Dyne Therapeutics ) average time for price targets to be met?

On average it took 237.2 days on average for the stock forecasts to be realized with a an average price target met ratio 51.45

Which analyst has the current highest performing score on DYN (Dyne Therapeutics ) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on DYN (Dyne Therapeutics )?

Francois Brisebois works at OPPENHEIMER and has 3 price targets and 3 ratings on DYN

Which analyst is the currently most bullish on DYN (Dyne Therapeutics )?

Michael Ulz with highest potential upside - $42.15

Which analyst is the currently most reserved on DYN (Dyne Therapeutics )?

Tessa Romero with lowest potential downside - -$0.85

Dyne Therapeutics  in the News

Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

– FDA (CDER) Type C meeting held in May 2025 for DYNE-101 in DM1 and Dyne plans to provide a regulatory update following receipt of meeting minutes – – Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 initiated to support potential submission for U.S. Accelerated Approval in H1 2026 – – Registrational Expansion...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?